Neurology Alert – August 1, 2012
August 1, 2012
View Issues
-
Inflammatory Myopathy Associated with Antimitochondrial Antibodies
Specific antibody-mediated inflammatory myopathies are being better defined and classified within the spectrum of dermatomyositis and polymyositis. -
Limbic Encephalitis: An Update
The diagnosis of limbic encephalitis should be considered in patients who present with progressive memory deficits, confusion, and seizures, as it is a treatable entity in many cases and may suggest the presence of an underlying malignancy. -
Reflexes in Guillain-Barré Syndrome
Normal or hyperactive reflexes do not necessarily rule out a diagnosis of Guillain-Barré' syndrome. -
Stroke Alert: A Review of Current Clinical Stroke Literature
Intravenous Thrombolysis is Relatively Safe and Effective in Elderly Patients Up to 6 Hours After Symptom Onset; Meta-analysis of All Randomized Trials Supports the Benefits of Intravenous Thrombolysis for All Patients Up to 6 Hours; Fabry Disease is Rarely Associated with Stroke in Young Adults; Major Perioperative Hemorrhage is Associated with an Increased Risk of Myocardial Infarction and Stroke -
Importance of Establishing National Multicenter Consortium for Neuromyelitis Optica Spectrum Disorders
Based on a retrospective analysis of 187 patients with neuromyelitis optica (NMO) or an NMO spectrum disorder from three medical centers, the authors report their initial findings on the epidemiology of NMO/NMO spectrum disorders. -
Six-month Outcome After Meningioma Removal
Meningioma surgery can be performed with good results in the elderly, but with increased complications and mortality. -
Pharmacology Watch: FDA Approves First New Anti-Obesity Drug in Years
Lorcaserin for weight loss; statins and fatigue; treatment-resistant gonorrhea; hydrocodone classification changes; USPSTF recommendations; and FDA actions. -
Clinical Briefs in Primary Care Supplement